NYSE:AGN
Delisted
Allergan plc Stock News
$193.02
+0 (+0%)
At Close: Sep 04, 2020
Jack Ma to relinquish Ant Group, Allergan settles opioid lawsuit, Shell posts record profits
11:04am, Thursday, 28'th Jul 2022
Yahoo Finance anchor Julie Hyman reports the latest notable business headlines include billionaire Jack Ma planning to relinquish control of fintech giant Ant Group, Pharmaceutical company Allergan se
AbbVie's Allergan reaches $2 billion opioid lawsuit settlement - Bloomberg News
06:18pm, Wednesday, 27'th Jul 2022
AbbVie Inc's unit Allergan has reached an agreement to pay over $2 billion to resolve thousands of lawsuits related to the marketing of its opioid painkiller, Bloomberg News reported on Wednesday, cit
San Francisco reaches $54 million opioid settlement with Teva and Allergan
10:27am, Tuesday, 12'th Jul 2022
Teva Pharmaceutical Industries Inc and AbbVie's Allergan business unit reached a $58 million opioid settlement with the city of San Francisco over claims that they fueled an opioid epidemic in the cit
Teva, Allergan reach $161.5 million opioid settlement with West Virginia
10:03am, Wednesday, 25'th May 2022
(Reuters) -Teva Pharmaceutical Industries and AbbVie's Allergan unit reached a settlement worth $161.5 million to resolve claims the companies fueled an opioid epidemic in West Virginia, state attorne
Allergan Shares Topline Data For Twice Daily Vuity (Pilocarpine) In Blurry Vision Study
02:45pm, Tuesday, 05'th Apr 2022
Allergan, an AbbVie Inc (NYSE: ABBV) company, announced topline data from Phase 3 VIRGO trial evaluating Vuity (pilocarpine HCl ophthalmic solution) 1.25% in adults with presbyopia, age-related blur
Allergan Shares Updated Data From Vision Loss Candidate Showing Significant Improvement In Near-Vision Reading
06:52am, Monday, 26'th Jul 2021
Allergan, a unit of AbbVie Inc (NYSE: ABBV), has announced new data, including the full results from the Phase 3 GEMINI 1 study of AGN-190584 (pilocarpine 1.25%) ophthalmic solution for presbyopia.
Firms fined £260mln for 10,000% rise in price of NHS hydrocortisone tablets
03:31am, Thursday, 15'th Jul 2021
A group of companies including Irish drug giant Allergan PLC (NYSE:AGN) and private equity group Cinven have been fined more than £260mln for rigging prices of hydrocortisone drugs sold to the NHS. U
Former Allergan CEO says pausing J&J vaccine is an 'overreaction'
04:55pm, Tuesday, 13'th Apr 2021
Brent Saunders, former Allergan CEO, joins 'Closing Bell' to discuss the FDA and CDC's decision to pause the J&J vaccine after six women developed rare blood clots after they received the vaccine. The
Los Angeles, California--(Newsfile Corp. - April 13, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of All
Los Angeles, California--(Newsfile Corp. - April 2, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Al
AbbVie's Allergan Files US Application AGN-190584 For Presbyopia
01:43pm, Thursday, 25'th Feb 2021
Allergan, an AbbVie Inc (NYSE: ABBV), has submitted a marketing application to the FDA for investigational AGN-190584 (pilocarpine 1.25%) ophthalmic solution for the treatment of presbyopia. The
Worldwide Facial Injectable Industry to 2025 - by Type, Generation, End-user and Geography
05:13am, Wednesday, 24'th Feb 2021
Dublin, Feb. 24, 2021 (GLOBE NEWSWIRE) -- The "Facial Injectable Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering. The facial injectable market is proje
Allergan's BOTOX Wins FDA Nod For Neurologic Condition-Associated Pediatric Detrusor Overactivity
11:05am, Wednesday, 10'th Feb 2021
The FDA has approved Allergan and AbbVie Inc's (NYSE: ABBV) BOTOX (onabotulinumtoxinA). It is used to treat detrusor (bladder muscle) overactivity associated with a neurologic condition in pediat
Los Angeles, California--(Newsfile Corp. - October 29, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Allergan plc
Los Angeles, California--(Newsfile Corp. - October 27, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Allergan plc (
